1,3-OXAZOLIDINE OR 1,3-OXAZINANE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS
A heteroaromatic methyl cyclic amine derivative represented by formula (IA) or a pharmaceutically acceptable salt thereof is useful for treatment or prophylaxis of diseases such as sleep disorder, depression, anxiety disorder, panic disorder, schizophrenia, drug dependence, Alzheimer's disease,...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English Portuguese |
Published |
13.03.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A heteroaromatic methyl cyclic amine derivative represented by formula (IA) or a pharmaceutically acceptable salt thereof is useful for treatment or prophylaxis of diseases such as sleep disorder, depression, anxiety disorder, panic disorder, schizophrenia, drug dependence, Alzheimer's disease, Parkinson's disease, Huntington's disease, eating disorder, cephalalgia, hemicrania, pain, digestive diseases, epilepsy, inflammation, immune-related diseases, endocrine-related diseases and hypertension, on the basis of an orexin (OX) receptor antagonist activity. |
---|---|
AbstractList | A heteroaromatic methyl cyclic amine derivative represented by formula (IA) or a pharmaceutically acceptable salt thereof is useful for treatment or prophylaxis of diseases such as sleep disorder, depression, anxiety disorder, panic disorder, schizophrenia, drug dependence, Alzheimer's disease, Parkinson's disease, Huntington's disease, eating disorder, cephalalgia, hemicrania, pain, digestive diseases, epilepsy, inflammation, immune-related diseases, endocrine-related diseases and hypertension, on the basis of an orexin (OX) receptor antagonist activity. |
Author | YUKO ARAKI MASAHITO ABE DAI NOZAWA RYO SUZUKI HIROSHI OHTA AYA FUTAMURA |
Author_xml | – fullname: YUKO ARAKI – fullname: MASAHITO ABE – fullname: DAI NOZAWA – fullname: AYA FUTAMURA – fullname: HIROSHI OHTA – fullname: RYO SUZUKI |
BookMark | eNrjYmDJy89L5WTwNNQx1vWPcIzy9_F08fRzVfAPUoAJefo5AgWc_X0D_EP9XIIVHIOBsq4Rnn4KQa7OrgEhQKWOfiGO7v5-nsEhwTwMrGmJOcWpvFCam0HBzTXE2UM3tSA_PrW4IDE5NS-1JD4gxMjCDIgMQkKMiVACANzeLt4 |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | COMPOSTOS DE 1,3-OXAZOLIDINA OU 1,3-OXAZINANO COMO ANTAGONISTAS DO RECETOR DE OREXINA |
ExternalDocumentID | PT2862860TT |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_PT2862860TT3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 12:48:57 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Portuguese |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_PT2862860TT3 |
Notes | Application Number: PT20130804876T |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170313&DB=EPODOC&CC=PT&NR=2862860T |
ParticipantIDs | epo_espacenet_PT2862860TT |
PublicationCentury | 2000 |
PublicationDate | 20170313 |
PublicationDateYYYYMMDD | 2017-03-13 |
PublicationDate_xml | – month: 03 year: 2017 text: 20170313 day: 13 |
PublicationDecade | 2010 |
PublicationYear | 2017 |
RelatedCompanies | TAISHO PHARMACEUTICAL CO., LTD |
RelatedCompanies_xml | – name: TAISHO PHARMACEUTICAL CO., LTD |
Score | 3.0759056 |
Snippet | A heteroaromatic methyl cyclic amine derivative represented by formula (IA) or a pharmaceutically acceptable salt thereof is useful for treatment or... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | 1,3-OXAZOLIDINE OR 1,3-OXAZINANE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170313&DB=EPODOC&locale=&CC=PT&NR=2862860T |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LTsMwzBoDATcYIMZLPaCeqFjXFLZDhbo0Y0UsqdYMVVxQ0qWCyzaxIn6fpFqBC9wiO7JsS7bjxHYALlUf5Qgh6bj-TDlI9LUf7AnPUUp0hVsIV3VMv_OY3oym6CHzswa81r0w1ZzQz2o4oraoXNt7Wfnr5c8lVlTVVq6u5ZsGLe6GPIjsdXbsmmnsnh0NApKwiGEb4yDhNp0E3Z7pwezwDdg0h2gzZZ88DUxPyvJ3QBnuwVaiac3LfWgsyxbs4PrftRZsj9fP3Xq5trzVAcTuleewLHxmj3EUU2KxiVWDYhpqAGbjhE1plFphqrEki6k1IZgkXG8NKQ_vGY1Tnh6CNSQcjxzN08u3-C8Jr5nn3hE054u5OgZLpx0mHZj5Ir9F0pey6HakFh_lPVH4xawN7T_JnPyDO4Vdo0dTZuV6Z9As3z_UuY67pbyoVPYFIKqCew |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LTsMwzBoDMW4wQIxnD6gnKtY1ZduhQl3ascCaVGuGKi5T07WCyzaxIn6fpFqBC9wiO7JsS7bjxHYArrM-ShFCwjDteWagpC_9YC-xjCxLOomZJ2bWVv3OAb0bTdFjbMc1eK16Yco5oZ_lcERpUam096L016ufSyyvrK1c34o3CVreD7nj6Zvs2FTT2C3dGzh-yDyGdYydkOt04nR6qgezzbdgu6tm86qD0_NA9aSsfgeU4T7shJLWojiA2qpoQgNX_641YTfYPHfL5cby1odAzBvLYLH7wsbEI9TX2ESrQIS6EoBZELIp9SLNjSTWjwnVJj72Qy63upS7D4ySiEdHoA19jkeG5Gn2Lf4s5BXz3DqG-mK5yE5Ak2mHSgfmdpJ2kbCFyDttIcVHaS_J7XzegtafZE7_wV1BY8SD8WxM6NMZ7CmdqpIr0zqHevH-kV3IGFyIy1J9X2NqhWg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=1%2C3-OXAZOLIDINE+OR+1%2C3-OXAZINANE+COMPOUNDS+AS+OREXIN+RECEPTOR+ANTAGONISTS&rft.inventor=YUKO+ARAKI&rft.inventor=MASAHITO+ABE&rft.inventor=DAI+NOZAWA&rft.inventor=AYA+FUTAMURA&rft.inventor=HIROSHI+OHTA&rft.inventor=RYO+SUZUKI&rft.date=2017-03-13&rft.externalDBID=T&rft.externalDocID=PT2862860TT |